0001209191-14-060592.txt : 20141001
0001209191-14-060592.hdr.sgml : 20141001
20141001171638
ACCESSION NUMBER: 0001209191-14-060592
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140930
FILED AS OF DATE: 20141001
DATE AS OF CHANGE: 20141001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pace Megan E
CENTRAL INDEX KEY: 0001554979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141133896
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-09-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001554979
Pace Megan E
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP, Corp. Communications
Common Stock
2014-09-30
4
M
0
1172
38.80
A
24522
D
Common Stock
2014-09-30
4
M
0
5625
51.75
A
30147
D
Common Stock
2014-09-30
4
M
0
3532
37.86
A
33679
D
Common Stock
2014-09-30
4
M
0
15250
48.74
A
48929
D
Common Stock
2014-09-30
4
M
0
17157
45.11
A
66086
D
Common Stock
2014-09-30
4
M
0
6875
83.36
A
72961
D
Common Stock
2014-09-30
4
M
0
6875
77.31
A
79836
D
Common Stock
2014-09-30
4
S
0
7576
111.32
D
72260
D
Common Stock
2014-09-30
4
S
0
21881
112.21
D
50379
D
Common Stock
2014-09-30
4
S
0
15400
113.08
D
34979
D
Common Stock
2014-09-30
4
S
0
11629
113.90
D
23350
D
Stock Option (right to buy)
38.80
2014-09-30
4
M
0
1172
0.00
D
2021-02-02
Common Stock
1172
2344
D
Stock Option (right to buy)
51.75
2014-09-30
4
M
0
5625
0.00
D
2021-07-12
Common Stock
5625
1875
D
Stock Option (right to buy)
37.86
2014-09-30
4
M
0
3532
0.00
D
2022-02-01
Common Stock
3532
4218
D
Stock Option (right to buy)
48.74
2014-09-30
4
M
0
15250
0.00
D
2022-07-24
Common Stock
15250
15250
D
Stock Option (right to buy)
45.11
2014-09-30
4
M
0
17157
0.00
D
2023-02-04
Common Stock
17157
28593
D
Stock Option (right to buy)
83.36
2014-09-30
4
M
0
6875
0.00
D
2023-07-29
Common Stock
6875
20625
D
Stock Option (right to buy)
77.31
2014-09-30
4
M
0
6875
0.00
D
2024-02-04
Common Stock
6875
48125
D
Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $111.32 (range $110.61 to $111.60).
Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60).
Open market sales reported on this line occurred at a weighted average price of $113.08 (range $112.61 to $113.59).
Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.62 to $114.32).
The option vests in 16 quarterly installments from 02/03/2011.
The option vests in 16 quarterly installments from 07/13/2011.
The option vests in 16 quarterly installments from 02/02/2012.
The option vests in 16 quarterly installments from 07/25/2012.
The option vests in 16 quarterly installments from 02/05/2013.
The option vests in 16 quarterly installments from 07/30/2013.
The option vests in 16 quarterly installments from 02/05/2014.
Kenneth L. Horton, Attorney-In-Fact
2014-10-01